Please login to the form below

Not currently logged in
Email:
Password:

Doctors.net.uk appoints new business development manager

Amanda Taylor joins from life sciences organisation OBN UK

Doctors.net.uk Amanda TaylorUK-based online doctor community Doctors.net.uk has appointed Amanda Taylor as its business development manager.

She will be tasked with working across all the key sectors for the company, including pharma, medical devices and private care, and joins from life sciences organisation OBN UK Ltd.

Taylor spent two and a half years at OBN, which supports and brings together emerging life science companies, corporate partners and investors, working in a business development role.

Prior to OBN, she worked for Oxford Immunotec, where she was responsible for the set up and management of Oxford Diagnostic Laboratories, which offers a national routine testing service to aid UK-based laboratories and clinicians in the diagnosis of latent TB infection and TB disease.

Dr Tim Ringrose, CEO of Doctors.net.uk, said: “We are delighted to welcome Amanda to Doctors.net.uk. Her extensive knowledge of the life sciences and biopharmaceutical sectors, and her business development expertise, will be a great asset to the team, and we look forward to working with her.”

20th August 2013

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics